Product: BUFFERED LIDOCAINE 1%+EPI 1:100,000 INJ SOL, [3ML NDC:  70731-0137-03 and 30ML NDC: 70731-0137-30] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.  NDC: 70731-0137-03
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20190619
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated